- Conditions
- Active Melanoma Brain Metastases
- Interventions
- Cobimetinib, Vemurafenib
- Drug
- Lead sponsor
- Melissa Burgess, MD
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 5 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2016
- U.S. locations
- 6
- States / cities
- New Haven, Connecticut • Iowa City, Iowa • New York, New York + 2 more
Source: ClinicalTrials.gov public record
Updated Oct 11, 2017 · Synced May 21, 2026, 6:47 PM EDT